P-glycoprotein

P-糖蛋白 (P-gp) 又称多药耐药蛋白 1 (MDR1),是一种重要的细胞膜蛋白,可将许多外来物质泵出细胞。更正式地说,它是一种具有广泛底物特异性的 ATP 依赖性外排泵。P-gp 广泛分布和表达于肠上皮中,它将外来化合物(如毒素或药物)泵回肠腔,在肝细胞中,它将它们泵入胆管,在肾近端小管细胞中,它将它们泵入尿管,在构成血脑屏障和血睾屏障的毛细血管内皮细胞中,它将它们泵回毛细血管。一些癌细胞也表达大量 P-gp,这使得这些癌症具有多药耐药性。P-gp 是一种具有广泛底物特异性的 ATP 依赖性外来化合物药物外排泵。它负责减少耐多药细胞中的药物积累,并经常介导对抗癌药物的耐药性的发展。这种蛋白质还充当血脑屏障中的转运蛋白。

P-glycoprotein (P-gp) also known as multidrug resistance protein 1 (MDR1) is an important protein of the cell membrane that pumps many foreign substances out of cells. More formally, it is an ATP-dependent efflux pump with broad substrate specificity. P-gp is extensively distributed and expressed in the intestinal epithelium where it pumps xenobiotics (such as toxins or drugs) back into the intestinal lumen, in liver cells where it pumps them into bile ducts, in the cells of the proximal tubular of the kidney where it pumps them into urine-conducting ducts, and in the capillary endothelial cells comprising the blood–brain barrier and blood-testis barrier, where it pumps them back into the capillaries. Some cancer cells also express large amounts of P-gp, which renders these cancers multi-drug resistant. P-gp is an ATP-dependent drug efflux pump for xenobiotic compounds with broad substrate specificity. It is responsible for decreased drug accumulation in multidrug-resistant cells and often mediates the development of resistance to anticancer drugs. This protein also functions as a transporter in the blood–brain barrier.

共 1种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
TP-9201

TP-9201 是一种血小板 glycoprotein(GP)IIb/IIIa 受体拮抗剂,通过抑制 GPIIb/IIIa 与纤维蛋白原的相互作用来抑制血小板聚集,对二磷酸腺苷 (ADP) (MS-K59718) 诱导的人类、狒狒和狗血小板聚集显示出相似的抑制活性 (IC50 = 1-3 μM),而在兔 (IC50 = 45 μM) 和大鼠 (IC50 = 20 μM) 中活性较低,可用于研究动脉溶栓后预防再血栓形成。

138297-15-1
Antagonist
TP-9201

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础